Skip to main content

Animations

MJFF Publications

1621 - 1630 of 6403 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2023
  • 2024
  • 2011
  • 2017
  • 2020
  • 2024
  • 2018
  • 2021
  • Summary Details
    OPEN
    Title: Feedforward activation of PRKN/parkin
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15548627.2022.2100615
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Common signatures of differential microRNA expression in Parkinson’s and Alzheimer’s disease brains
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcac274
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopy
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xpro.2022.102024
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Multiscale Modeling of Magnetoelectric Nanoparticles for the Analysis of Spatially Selective Neural Stimulation
    Journal Name: Advanced Healthcare Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/adhm.202302871
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
    Journal Name: The American Journal of Pathology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ajpath.2011.01.006
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30400-3
    Citation Count: 240
  • Summary Details
    OPEN
    Title: A novel homozygous KY variant causing a complex neurological disorder
    Journal Name: European Journal of Medical Genetics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejmg.2020.104031
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Effect of the mGlu 2 positive allosteric modulator biphenyl‐indanone A as a monotherapy and as adjunct to a low dose of L‐DOPA in the MPTP‐lesioned marmoset
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16454
    Citation Count: 3
  • Summary Details
    OPEN
    Title: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles
    Journal Name: Nanomedicine: Nanotechnology, Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Advances in protein-protein interaction network analysis for Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395
    Citation Count: 68
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.